Cargando…
AROS Is a Significant Biomarker for Tumor Aggressiveness in Non-cirrhotic Hepatocellular Carcinoma
Despite a low risk of liver failure and preserved liver function, non-cirrhotic hepatocellular carcinoma (HCC) has a poor prognosis. In the current study, we evaluated an active regulator of SIRT1 (AROS) as a prognostic biomarker in non-cirrhotic HCC. mRNA levels of AROS were measured in tumor and n...
Autores principales: | Kwon, Jung-Hee, Ahn, Keun Soo, Moon, Young Ho, Park, Jin Young, Wang, Hee Jung, Choi, Kwan Yong, Kim, Gundo, Joh, Jae Won, Lee, Kyeong Geun, Kang, Koo Jeong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Academy of Medical Sciences
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4553671/ https://www.ncbi.nlm.nih.gov/pubmed/26339164 http://dx.doi.org/10.3346/jkms.2015.30.9.1253 |
Ejemplares similares
-
Actionable Gene Expression-Based Patient Stratification for Molecular Targeted Therapy in Hepatocellular Carcinoma
por: Kwon, Jung-Hee, et al.
Publicado: (2013) -
Major QTLs, qARO1 and qARO9, Additively Regulate Adaxial Leaf Rolling in Rice
por: Jang, Su, et al.
Publicado: (2021) -
The usefulness of non-invasive liver stiffness measurements in predicting clinically significant portal hypertension in cirrhotic patients: Korean data
por: Hong, Won Ki, et al.
Publicado: (2013) -
Clinicopathological and prognostic significance of PKM2 protein expression in cirrhotic hepatocellular carcinoma and non-cirrhotic hepatocellular carcinoma
por: Liu, Yan, et al.
Publicado: (2017) -
Dobutamine stress echocardiography for evaluating cirrhotic cardiomyopathy in liver cirrhosis
por: Kim, Moon Young, et al.
Publicado: (2010)